Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice-Reference-Cited by-同舟云学术

Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice

Published:2020-06-01 Issue:3 Volume:9 Page:449-452
ISSN:2156-5333
Container-title:Journal of Adolescent and Young Adult Oncology
language:en
Short-container-title:Journal of Adolescent and Young Adult Oncology

Author:

Conry Alexandra¹,Peters Melissa²,Fried Daniel B.²,Adams Amy¹,Campbell Alfred W.²,Bearden James D.²,Siegel Robert D.¹,Crosswell Howland E.¹

Affiliation:

1. Bon Secours St. Francis Health System, St. Francis Cancer Center, Greenville, South Carolina, USA.

2. Spartanburg Regional Health System, Gibbs Cancer Center & Research Institute, Spartanburg, South Carolina, USA.

Publisher

Mary Ann Liebert Inc

Subject

Oncology,Pediatrics, Perinatology, and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/jayao.2019.0113

Reference27 articles.

1. Alveolar soft-part sarcoma: a review and update

2. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups

3. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

4. Facilitating Teamwork in Adolescent and Young Adult Oncology

5. Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry;ESMO Open;2023-12

2. Atezolizumab for Advanced Alveolar Soft Part Sarcoma;New England Journal of Medicine;2023-09-07

3. Comparative Combinatorial Implications and Theranostics of Immunotherapy in the Impediment of Alveolar Soft Part Sarcoma;Current Pharmaceutical Design;2022-11

4. Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors;Pediatric Blood & Cancer;2022-05-20

5. Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report;Annals of Palliative Medicine;2021-01